Commit To Purchase Summit Therapeutics At $15, Earn 28.7% Annualized Using Options
February 25, 2025 at 13:52 PM EST
Investors eyeing a purchase of Summit Therapeutics Inc (SMMT) stock, but cautious about paying the going market price of $18.30/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $15 strike, which has a bid at the time of this writing of $3.50..
